Outcome of AGM
Sun Pharmaceutical Industries Ltd has informed BSE that the 24th Annual General Meeting (AGM) of the Company was held on September 17, 2016.17-09-2016
17-09-2016
Sun Pharma's high cash levels draw criticism
Firm says treasury team has done a commendable job15-09-2016
Sun Pharma buyback offer to open on 22 September
The buyback aims to return surplus funds to shareholders and enhance overall returns for them, said Sun Pharma14-09-2016
Updates on Buy back Offer
Sun Pharmaceutical Industries Ltd has submitted to BSE a copy of Letter of Offer regarding Offer to buyback not exceeding 75,00,000 (Seventy Five Lakhs) fully paid up Equity Shares of the Sun Pharmaceutical Industries Ltd ("Target Company") Company of face value of Re. 1/- (Rupee One only) each at a price of Rs. 900/- (Rupees Nine Hundred Only) per Equity Share on a proportionate basis through the Tender Offer process using Stock Exchange Mechanism (Buyback).14-09-2016
Sun Pharma medical representatives to go on strike
The strike is also against company's decision to have a uniform structure for paid leave for employees11-09-2016
Buy Sun Pharmaceutical Industries Ltd., target Rs 840.0 : Kunal Bothra
Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 840.0 and a stop loss at Rs 780.0 from entry point09-09-2016
Buy Sun Pharmaceutical Industries Ltd., target Rs 808.0 : Ruchit Jain
Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 808.0 and a stop loss at Rs 764.0 from entry point07-09-2016
Sun Pharma partners Mitsubishi Tanabe to sell 14 prescription brands in Japan
Out of the 14 prescription brands, 11 will be re-launched by Sun Pharma-Mitsubishi in the Japanese market by the end of December06-09-2016
Sun Pharma announces distribution alliance with Mitsubishi Tanabe Pharma Corporation in Japan
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated September 06, 2016, titled "Sun Pharma announces distribution alliance with Mitsubishi Tanabe Pharma Corporation in Japan".06-09-2016
Pharma cos offer freebies to doctors, violate code: MP
MUMBAI: A Rajya Sabha Member of Parliament has alleged that four drug companies have bribed doctors across India to push their products, violating the Medical Council of India's code of conduct. USV, Abbott Laboratories, Macleods Pharmaceuticals and Sun Pharmaceuticals allegedly sponsored "pleasure trips" for doctors or, in some cases, doled out cash in violation of the code of conduct, Tapan Sen, a Communist Party of India (M) MP, wrote in a letter to minister of chemicals & fertilisers Ananth Kumar. The letter dated August 18 was reviewed by ET. The department of pharmaceuticals said in a report in July that there was a need to take up the issue in the interest of consumers and patients as such promotional expenses extended to doctors had a direct implication on the pricing of drugs and affordability. In addition, the Comptroller & Auditor General, in a report in 2015, criticised the Central Board of Direct Taxes for allowing promotional expenses by pharma companies as deductible expenses while calculating tax. "I am waiting for the minister's response on this issue. Nothing has come so far. We also have the names of the doctors who have taken bribes, which we will release eventually," Sen told ET. Three of the companies denied any wrongdoing and one could not be reached for comment. Sen lists allegations such as Sun Pharma paying for tickets for a pleasure trip to Srinagar for nine doctors and its Stancare division picking up the hotel bill for a doctor; money paid by USV to 13 doctors for a...30-08-2016